Global Polyol Sweeteners Market is expanding as Major Industry Leader Cargill, Inc. Introduces a New Sweeteners to Reduce Sugar and Calorie Content in Beverages

 

polyol-sweeteners-market

Polyol is a type of sugar that has a longer shelf life than regular sugar and its popularity has been on the rise in recent times. Polyol is known to be more stable for use as a stabilizing agent. The popularity of this sweetener has been attributed to its anti-microbial and antioxidant properties. It also helps in lowering the pH level in the stomach thereby reducing acid reflux. It does not cause any harm to the digestive system and is easily absorbed by the body. Polyol is produced naturally in the environment as it occurs naturally in nuts, seeds, grains, and seaweeds. It was until recently believed that polls had no significant effect on health but recent researches have proved that they can help in weight loss.

Rising disposable and net national income per capita and changing lifestyles are expected to drive growth of the global polyol sweeteners market during the forecast period. According to the World Bank, global adjusted net national income per capita reached US$ 9,290 in 2018, increasing from US$ 8,507 in 2011. According to the Organisation for Economic Co-operation and Development (OECD), housing disposable income in the U.S. reached US$ 53,123 in 2018. Besides, the lifestyles of consumers is changing rapidly with consumers across the globe eating healthier food products. Thus, these factors are expected to drive growth of the global polyol sweeteners market growth over the forecast period. Furthermore, increasing consumer demand for low-calorie and healthier food & beverage products is expected to boost the global polyol sweeteners market growth over the forecast period. Polyol sweeteners have lower caloric value and are based on corn and sugar derivatives.

However, high cost of production of food & beverage products with polyol sweeteners as compared to sugar is expected to hinder the global polyol sweeteners market growth over the forecast period. Besides, continuous research and development activities to develop safer sugar substitutes can present lucrative growth opportunities in the global polyol sweeteners market in the near future. Among regions, Europe is expected to witness significant growth in the global polyol sweeteners market during the forecast period. This is owing to increasing demand for natural ingredients and rapid growth of the personal care industry in developed countries such as Italy, France, and Germany.

Key players involved in the global polyol sweeteners market are Cargill, Inc., Foodchem International Corp., Sweeteners Plus, LLC, Ingredion Inc., Sukhjit Starch & Chemicals Ltd., DuPont, Roquette Frères, Shandong Futaste Co., Zibo Shunda Biotech Co., Ltd., Mitsubishi Corporation Life Sciences Ltd., HYET Sweet, and SPI Pharma.

For instance, in July 2020, Cargill, Inc. introduced a new sweetener C TruSweet 01795 to boost a 30% sugar and calorie reduction in beverages.

Location: India

Comments

Post a Comment

Popular posts from this blog

The Emergence of COVID-19 to Augment Growth of the Outsourced Drug Discovery Market

Image
  With billions of dollars in research and development costs, pharmaceutical companies around the world are always looking for new ways to address their production processes in a cost-effective manner. One way to achieve this is through outsourcing drug discovery and development services. This type of service refers to the collaboration between small and large biotech and biotechnology companies to conduct research and development activities aimed at finding better solutions to the company's core chemical concerns. Outsourcing of these drug discovery services has enabled established pharmaceutical and biotechnology companies to focus on the development of new products that can bring about significant therapeutic change and provide tangible advantages to the company's shareholders. Contract research organizations manage almost all aspects of drug discovery. Market Dynamics I ncreasing demand for outsourcing analytical testing and clinical trial services, growing R&D ex...
Read more

Otoscope Market Is Gaining Major Traction with Industry Leader Otonexus Medical Technologies Introducing Ultrasound Sensor, Which Aids Middle-Ear Infection Diagnosis

Image
  An otoscope or auricular ear picker is a simple health care tool that is used to inspect the outer ear. Many health care professionals utilize otoscopes to examine ear infections during routine check-ups and to also screen for serious ear disorders. An otoscope possibly provides a more detailed view of the external ear canal and/or ear drum or eardrum. Otoscope or also referred to as auriscope is mainly used to look into eyes. The demand for these medical devices has been on a rise in the recent past. This is typically due to the fact that there is a high burden of ENT-related diseases across the globe. As per the World Health Organization (WHO), by 2050, around 2.5 billion people are estimated to have some degree of hearing loss worldwide. Similarly, there is a heavy burden of sinusitis cases. As per the Sinusitis & Allergy Wellness Center, around 30 million adults in the U.S. are impacted with sinusitis annually. Such a high prevalence of ENT disorders has accelerated the d...
Read more

The Number of Cancer Survivors Is Projected To Increase to 22.2 Million By 2030 Fostering Oncology Drug Pipeline Analysis Market

Image
  North America is estimated to dominate the global oncology drug pipeline analysis market in the near future and this is attributed to the high prevalence of cancer and increasing launch of various novel drugs with improved efficacy. According to the National Cancer Institute, as of January 2019, there were an estimated 16.9 million cancer survivors in the United States. The number of cancer survivors is projected to increase to 22.2 million by 2030. The oncology field is experiencing significant growth and this is attributed to the increasing development of various novel therapies for the treatment of cancer. For instance, in February 2021, Rhizen Pharmaceuticals AG, a clinical-stage, oncology-focused biopharma company, with a 50% stake owned by Alembic Pharmaceuticals and the rest by its Indian CEO Swaroop Vakkalanka, has announced that its the novel, next-generation PI3K-delta inhibitor Umbralisib (Ukoniq) has secured U.S. FDA accelerated approval for the treatment of blood c...
Read more